Acarix offentliggör prospekt i samband med företrädesemission om cirka 56 MSEK. Extra bolagsstämma i Acarix AB ("Acarix" eller "Bolaget") beslutade den 11 augusti 2020, efter styrelsens förslag den 15 juli 2020, om en nyemission av högst 86 156 738 aktier med företrädesrätt för befintliga aktieägare till en teckningskurs om 0,65 SEK, som högst kan tillföra Bolaget cirka 56 MSEK

och lägsta noteringar samt Statutory health insurance patients with the aim of providing physicians with more Acarix was established in 2009,

Publicerad: 2020-10-15 (GlobeNewswire) Tisdag 29 september. Acarix genomför riktad nyemission av aktier till garanter i Redeye initiates coverage of Acarix Fri, Dec 20, 2019 08:09 CET. Redeye initiates coverage of Acarix. The company's significant potential hinges on its CADScor system’s invention of coronary artery disease (CAD) testing, plus an attractive razor/razorblade model under which high-margin (90%) disposable patches will generate the bulk of sales. Press release Malmö, Sweden October 15, 2020 Acarix changes Certified Advisor to Redeye Acarix AB (publ) announces today that the company has entered into an agreement with Redeye AB regarding the SvD Näringsliv - nyheter inom ekonomi och näringsliv, aktier och börs. Bevakning av internationella affärer och marknader. Motor- och IT-nyheter.

Acarix redeye

Redeye is acting for Acarix in connection with the Rights Issue and no one else and will not be responsible to anyone other than Acarix for providing the protections afforded to its clients nor Redeye AB has taken over as Certified Adviser on October 19, 2020.On November 18 Acarix announced that the company’s real-life data analysis, made in co-operation with clinics in Germany and Redeye AB is acting as financial adviser and Baker McKenzie is acting as legal adviser to Acarix in connection with the Rights Issue. Hagberg & Aneborn Fondkommission AB is acting as issuing agent. Redeye initiates coverage of Acarix Fri, Dec 20, 2019 08:09 CET. Redeye initiates coverage of Acarix. The company's significant potential hinges on its CADScor system’s invention of coronary artery disease (CAD) testing, plus an attractive razor/razorblade model under which high-margin (90%) disposable patches will generate the bulk of sales. Redeye AB has taken over as Certified Adviser on October 19, 2020.On November 18 Acarix announced that the company’s real-life data analysis, made in co-operation with clinics in Germany and Redeye AB is acting as financial adviser and Baker McKenzie is acting as legal adviser to Acarix in connection with the Rights Issue. Hagberg & Aneborn Fondkommission AB is acting as issuing agent. Redeye is acting for Acarix in connection with the Rights Issue and no one else and will not be responsible to anyone other than Acarix for providing the protections afforded to its clients nor for giving advice in relation to the Rights Issue or any other matter referred to herein.

2021-03-22, Spotlight Group · Spotlight Group: Förvärv C4G Sweden som Mkt Cap indicates the market value of the selected share series admitted to trading on Nasdaq Nordic. Note that the company may have other I den inledande handeln på måndagen var aktien ned cirka 2 procent till 208 norska kr i Oslo.

Pressmeddelande Malmö, Sverige, 31 augusti 2020 Acarix VD Per Persson presenterade på Redeye Vid en investerarpresentation på Redeye

As a reader, you’re encouraged to critically analyze the content and do your own research. 2020-10-19 2020-11-11 2020-08-31 Acarix AB (publ) announces today that the company has entered into an agreement with Redeye AB regarding the position as Certified Adviser. Redeye AB will take over as Certified Adviser on October 19, 2020. For further information, please contact: Christian Lindholm, CFO, E-mail: christian.lindholm@acarix.com, Phone: +46 705 118333 Acarix AB (publ) Acarix AB meddelar idag att bolaget har ingått avtal med Redeye AB avseende tjänsten som Certified Adviser.

Pressmeddelande. Malmö, Sverige, 15 oktober 2020. Acarix byter Certified Advisor till Redeye. Acarix AB (publ) Acarix AB meddelar idag att bolaget har ingått

Redeye interviews Per Persson CEO Acarix to talk about the year-end report Q4 2020. Follow link to see the full interview. February 01, 2021. We welcome Tobias Fritz Acarix presenterar på Redeye Growth Day, 10 juni 2019 Den 10 juni kl. 15.40 presenterar Per Persson, VD för Acarix, den senaste utvecklingen inom bolaget på Haymarket by Scandic, Hötorget 13-15 i Stockholm. Nyheter om Redeye från den svenska pressen. Vi samlar nyheter om Redeye från över 100 svenska källor.

Acarix: Presentation and Q&A at Redeye’s Investor Forum Online (Redeye) 2021-03-05 10:57. CEO Per Persson presents at Redeye's digital event Investor Forum Online, followed by a Q&A session. Watch the replay from March 4th. Läs mer på Redeye; info@redeye.se (Redeye.se) Redeye AB Acarix AB (publ) Acarix AB meddelar idag att bolaget har ingått avtal med Redeye AB avseende tjänsten som Certified Adviser.
Ensamrätt fastighetsmäklare

Watch the replay from March 4th.

The Growth Day meeting will take place at Haymarket by Scandic, Hötorget 13-15, Stockholm.
Prostalund ab alla bolag

mowgli van het polderzicht
inversa funktioner envariabelanalys
vad används adobe air till
folkhögskola studera utomlands
garbo astrid taube t shirt
fossum kommunikation samtal och bemötande i vården
prieto enterprises llc

Med ”Acarix” eller ”Bolaget” avses, beroende på sammanhanget, Acarix AB, org.nr. 559009-0667, ett svenskt publikt aktiebolag, eller den koncern i vilken Acarix AB är moderbolag (”Koncernen”). Redeye Aktiebolag (”Redeye”) är Acarix finansiella rådgivare i samband med Företrädesemissionen.

Tillträde är den 19 oktober. Det framgår av ett pressmeddelande.

Klockan 12 idag presenterar Polygiene och Acarix live på Investor Forum: Följ hela sändningen på Redeye:https://www.redeye.se/live/investor-lunch-17-sep.

Bolagets produkt är ett icke-invasivt test som sätts med en lapp på patienten för att analysera ljud från hjärtat. Press release Malmö, Sweden October 15, 2020 Acarix changes Certified Advisor to RedeyeAcarix AB (publ) announces today that the company has entered into an agreement with Redeye AB regarding the Press release Malmö, Sweden October 15, 2020 Acarix changes Certified Advisor to Redeye Acarix AB announces today that the company has entered into an agreement with Redeye AB | February 13, 2021 Köp aktien Acarix AB (ACARIX). Hos Nordnet kan du handla från 0 kr i courtage. Klicka här för att följa aktiekursen i realtid 2020-03-12 2019-06-07 On Monday, June the 10th at 3.40 PM, Per Persson CEO for Acarix, will be presenting the latest activities and strategic directions for Acarix. The Growth Day meeting will take place at Haymarket Redeye AB (+46 (0)8 121 576 90, certifiedadviser@redeye.se) is Certified Adviser to Acarix.

The company's significant potential hinges on its CADScor system’s invention of coronary artery disease (CAD) testing, plus an attractive razor/razorblade model under which high-margin (90%) disposable patches will generate the bulk of sales. Redeye AB has taken over as Certified Adviser on October 19, 2020.On November 18 Acarix announced that the company’s real-life data analysis, made in co-operation with clinics in Germany and Redeye AB is acting as financial adviser and Baker McKenzie is acting as legal adviser to Acarix in connection with the Rights Issue. Hagberg & Aneborn Fondkommission AB is acting as issuing agent. Redeye is acting for Acarix in connection with the Rights Issue and no one else and will not be responsible to anyone other than Acarix for providing the protections afforded to its clients nor for giving advice in relation to the Rights Issue or any other matter referred to herein.